My Photo
Name:
Location: Red Bank, NJ

I have dedicated my law practice for the last 25 years to the wrongfully injured and their families. The purpose of this blog is not to provide legal advice. If you need legal help you can contact me at cplacitella@cprlaw.com or visit our website at www.cprlaw.com. Thank You

Thursday, December 21, 2006

Disparity Emerges in Lilly Data on Schizophrenia Drug - New York Times: "Disparity Emerges in Lilly Data on Schizophrenia Drug
Sign In to E-Mail or Save This
Print
Reprints
Share
Digg
Facebook
Newsvine
Permalink


By ALEX BERENSON
Published: December 21, 2006
For at least a year, Eli Lilly provided information to doctors about the blood-sugar risks of its drug Zyprexa that did not match data that the company circulated internally when it first reviewed its clinical trial results, according to company documents.
The original results showed that patients on Zyprexa, Lilly’s pill for schizophrenia, were 3.5 times as likely to experience high blood sugar levels as those taking a placebo, according to a February 2000 memo sent to top Lilly scientists. The memo is one of hundreds of internal Lilly documents provided to The New York Times by a lawyer in Alaska who represents mentally ill patients."

1 Comments:

Anonymous Daryl said...

It is hardly surprising that these things happen when those individual scientists who raise these problems are subjected to bullying and when the whistleblowers are shot. Small problems beget bigger problems. Some good articles are collated
here
http://honestmedicine.typepad.com/medical_watch/2006/12/ten_important_a.html

and
http://www.aaas.org/spp/sfrl/per/per46.pdf

Daryl

5:14 AM  

Post a Comment

Links to this post:

Create a Link

<< Home